Page last updated: 2024-10-17

lactic acid and Infections, Staphylococcal

lactic acid has been researched along with Infections, Staphylococcal in 60 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to investigate the curative effect of bone-like hydroxyapatite/poly amino acid (BHA/PAA) as a carrier for poly(lactic-co-glycolic acid)-coated rifapentine microsphere (RPM) in the treatment of rabbit chronic osteomyelitis induced by Staphylococcus aureus."7.81Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres. ( Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF, 2015)
"To prepare the vancomycin hydrochloride (VA)-loaded poly lactic acid-glycolic acid (PLGA) copolymer microsphere by the multiple emulsion method and evaluate its therapeutic effects on infective discitis."7.77Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study. ( Liu, F; Liu, J; Ni, B; Wang, F; Zhu, YZ; Zhu, Z, 2011)
"A novel biodegradable system of D-,L-dilactide delivering pefloxacin was implanted in 104 rabbits with experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus (MRSA), 26 serving as controls."7.70Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. ( Andreopoulos, A; Dounis, E; Galanakis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Karagianakos, P; Papakostas, K; Rifiotis, C, 2000)
"The purpose of this study was to investigate the curative effect of bone-like hydroxyapatite/poly amino acid (BHA/PAA) as a carrier for poly(lactic-co-glycolic acid)-coated rifapentine microsphere (RPM) in the treatment of rabbit chronic osteomyelitis induced by Staphylococcus aureus."3.81Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres. ( Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF, 2015)
"To prepare the vancomycin hydrochloride (VA)-loaded poly lactic acid-glycolic acid (PLGA) copolymer microsphere by the multiple emulsion method and evaluate its therapeutic effects on infective discitis."3.77Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study. ( Liu, F; Liu, J; Ni, B; Wang, F; Zhu, YZ; Zhu, Z, 2011)
" Systemic antibiotics often do not reach "dead-space" hematomas where bacteria harbor after surgery, whereas local, controlled release gentamicin prophylaxis through PLGA microspheres showed favorable pharmacokinetics data to achieve local bactericidal concentrations for up to 7 days after surgery."3.75Reduction of postoperative spinal implant infection using gentamicin microspheres. ( Becker, E; Gelb, D; Ludwig, SC; Poelstra, KA; Stall, AC, 2009)
"A novel biodegradable system of D-,L-dilactide delivering pefloxacin was implanted in 104 rabbits with experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus (MRSA), 26 serving as controls."3.70Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. ( Andreopoulos, A; Dounis, E; Galanakis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Karagianakos, P; Papakostas, K; Rifiotis, C, 2000)
"Healing of equine wounds, particularly in the limbs, is difficult due to hydrostatic factors and exposure to environmental contaminants, which can lead to heavy bio-burden/biofilm formation and sometimes to infection."1.43Fighting Off Wound Pathogens in Horses with Honeybee Lactic Acid Bacteria. ( Butler, É; Lindholm, C; Michanek, P; Nilson, B; Olofsson, TC; Vásquez, A, 2016)
"Titanium implants have been widely used for many medical applications, but bacterial infection after implant surgery remains one of the most common and intractable complications."1.42Antibacterial activity and biological performance of a novel antibacterial coating containing a halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium. ( Cheng, Y; Gao, B; Liu, X; Ren, H; Sun, W; Wu, J; Zhao, X, 2015)
"652 mg PLGA/ml) by MTT assay and the study of cellular up-take assessed on human fibroblasts confirmed the feasibility to formulate a dosage form useful for vaccination against S."1.39Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant. ( Caliceti, P; Colonna, C; Conti, B; Dorati, R; Genta, I, 2013)
" Hence, these microspheres may be potentially useful in the clinical setting with the need for further investigation for optimal dosing of TCP–PLGA microspheres."1.36Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. ( Ahiskali, R; Cevher, E; Mülazimoğlu, L; Orhan, Z; Sensoy, D; Yildiz, A, 2010)
"Osteomyelitis was established in 40 New Zealand White rabbits using Staphylococcus aureus."1.32Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. ( Ambrose, CG; Clyburn, TA; Gogola, GR; Gulati, P; Joseph, J; Louden, K; Mikos, AG; Wright, J, 2004)
"Osteomyelitis is generally treated by the systemic administration of antibiotics and continuous irrigation after curettage of the lesion, and bone graft is performed secondarily to treat any bone defect."1.30Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis. ( Ishii, Y; Sasaki, S, 1999)

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-19907 (11.67)18.7374
1990's8 (13.33)18.2507
2000's9 (15.00)29.6817
2010's29 (48.33)24.3611
2020's7 (11.67)2.80

Authors

AuthorsStudies
Schwenker, JA1
Schotte, U1
Hölzel, CS1
Karacan, I1
Ben-Nissan, B1
Santos, J1
Yiu, S1
Bradbury, P1
Valenzuela, SM1
Chou, J1
Baheerathan, A1
Pitceathly, RD1
Curtis, C1
Davies, NW1
Heim, CE1
Bosch, ME1
Yamada, KJ1
Aldrich, AL1
Chaudhari, SS1
Klinkebiel, D1
Gries, CM1
Alqarzaee, AA1
Li, Y1
Thomas, VC1
Seto, E1
Karpf, AR1
Kielian, T1
Da Costa, D1
Exbrayat-Héritier, C1
Rambaud, B1
Megy, S1
Terreux, R1
Verrier, B1
Primard, C1
Parente, CS1
Sandland-Taylor, LE1
Akhtar, W1
Wang, J1
Applefeld, WN1
Sun, J1
Solomon, SB1
Feng, J1
Couse, ZG1
Risoleo, TF1
Danner, RL1
Tejero, J1
Lertora, J1
Alipour, E1
Basu, S1
Sachdev, V1
Kim-Shapiro, DB1
Gladwin, MT1
Klein, HG1
Natanson, C1
Reinbold, J1
Hierlemann, T1
Urich, L1
Uhde, AK1
Müller, I1
Weindl, T1
Vogel, U1
Schlensak, C1
Wendel, HP1
Krajewski, S1
Bino, E1
Lauková, A2
Ščerbová, J2
Kubašová, I1
Kandričáková, A2
Strompfová, V1
Miltko, R1
Belzecki, G1
Colonna, C2
Dorati, R2
Conti, B2
Caliceti, P2
Genta, I2
Esnault, P1
Cotte, J1
Cungi, PJ1
Romanat, PE1
Boret, H1
McLaren, JS1
White, LJ1
Cox, HC1
Ashraf, W1
Rahman, CV1
Blunn, GW1
Goodship, AE1
Quirk, RA1
Shakesheff, KM1
Bayston, R1
Scammell, BE1
Kankilic, B2
Bilgic, E1
Korkusuz, P1
Korkusuz, F2
Neut, D1
Dijkstra, RJ1
Thompson, JI1
Kavanagh, C1
van der Mei, HC1
Busscher, HJ1
Cheng, Y1
Zhao, X1
Liu, X1
Sun, W1
Ren, H1
Gao, B1
Wu, J3
de Bree, LC1
van Rijen, MM1
Coertjens, HP1
van Wijngaarden, P1
Vitko, NP2
Spahich, NA1
Richardson, AR2
Yan, L1
Jiang, DM1
Cao, ZD1
Wang, X1
Wang, ZL1
Li, YJ1
Yi, YF1
de Breij, A1
Riool, M1
Kwakman, PH1
de Boer, L1
Cordfunke, RA1
Drijfhout, JW1
Cohen, O2
Emanuel, N2
Zaat, SA1
Nibbering, PH1
Moriarty, TF1
Lee, MY1
Bourgeois, S1
Almouazen, E1
Pelletier, J1
Renaud, F1
Fessi, H1
Kodjikian, L1
Olofsson, TC1
Butler, É1
Lindholm, C1
Nilson, B1
Michanek, P1
Vásquez, A1
Salmaso, S1
Speziale, P1
Pietrocola, G1
Chiesa, E1
Modena, T1
Stall, AC1
Becker, E1
Ludwig, SC1
Gelb, D1
Poelstra, KA1
Orhan, Z1
Cevher, E1
Yildiz, A1
Ahiskali, R1
Sensoy, D1
Mülazimoğlu, L1
Cardillo, JA1
Paganelli, F1
Melo, LA1
Silva, AA1
Pizzolitto, AC1
Oliveira, AG1
Wang, F1
Ni, B1
Zhu, Z1
Liu, F1
Zhu, YZ1
Liu, J1
de Sousa, FO1
Blanco-Méndez, J1
Pérez-Estévez, A1
Seoane-Prado, R1
Luzardo-Álvarez, A1
Bayramli, E1
Kilic, E1
Dağdeviren, S1
Said, SS1
El-Halfawy, OM1
El-Gowelli, HM1
Aloufy, AK1
Boraei, NA1
El-Khordagui, LK1
Lee, JH2
Gu, Y1
Wang, H1
Lee, WY1
Moon, SK1
Kim, KM1
Kim, KN1
Chen, L1
Li, S1
Wang, Z1
Chang, R1
Su, J1
Han, B1
Rosenfeld, Y1
Applbaum, YH1
Segal, D1
Barenholz, Y1
Jamal, T1
Rahman, MA1
Mirza, MA1
Panda, AK1
Talegaonkar, S1
Iqbal, Z1
Cai, W1
Xi, C1
Meyerhoff, ME1
Fuller, JR1
Perkowski, EF1
Scott, E1
Khatri, D1
Spontak, JS1
Thurlow, LR1
van Dijk, M1
Smit, TH1
Burger, EH1
Wuisman, PI1
Baumert, N1
von Eiff, C1
Schaaff, F1
Peters, G1
Proctor, RA1
Sahl, HG1
GERSHANOVITCH, VN1
PALKINA, NA1
BURD, GI1
ZAWISZA-ZENKTELER, W1
Ambrose, CG1
Clyburn, TA1
Louden, K1
Joseph, J1
Wright, J1
Gulati, P1
Gogola, GR1
Mikos, AG1
Koort, JK1
Mäkinen, TJ1
Suokas, E1
Veiranto, M1
Jalava, J1
Knuuti, J1
Törmälä, P1
Aro, HT1
Ludwick, JJ1
Rossmann, SN1
Johnson, MM1
Edmonds, JL1
Sayin, B1
Caliş, S1
Atilla, B1
Marangoz, S1
Hincal, AA1
Störmer, M1
Kleesiek, K1
Dreier, J1
Pollock, HM1
Ruf, B1
Stewart, KD1
Brackett, DJ1
Lerner, MR1
Archer, LT1
Wilson, MF1
Martynov, VA1
Roslyĭ, IM1
Kolobaeva, OV1
Calhoun, JH1
Mader, JT1
Benoit, MA1
Mousset, B1
Delloye, C1
Bouillet, R1
Gillard, J1
Sasaki, S1
Ishii, Y1
Kanellakopoulou, K1
Galanakis, N1
Giamarellos-Bourboulis, EJ1
Rifiotis, C1
Papakostas, K1
Andreopoulos, A1
Dounis, E1
Karagianakos, P1
Giamarellou, H1
Boddie, RL2
Nickerson, SC2
Watts, JL1
Ray, CH1
Höring, E1
Kubin, S1
von Gaisberg, U1
Musch, TI1
Martin, LF1
Topley, N1
Alobaidi, HM1
Davies, M1
Coles, GA1
Williams, JD1
Lloyd, D1
Evanchick, CE1
Davis, DE1
Harrington, TM1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Lumbar Interbody Fusion Using The Telamon® Peek™ Versus The Telamon® Hydrosorb™ Fusion Device - A Prospective, Randomized Controlled Trial To Assess Surgical And Clinical Outcomes[NCT00095095]Phase 4102 participants Interventional2004-10-31Terminated
A National, Prospective, Randomized, Multicenter, Controlled Head-to-Head Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute in Filling of Contained Bone Defects[NCT00841152]120 participants (Actual)Observational2009-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for lactic acid and Infections, Staphylococcal

ArticleYear
CSF lactate.
    Practical neurology, 2020, Volume: 20, Issue:4

    Topics: Adult; Biomarkers; Brain Diseases; Central Nervous System Infections; Enterovirus; Female; Humans; L

2020
Laboratory techniques for detection of urinary tract infection and assessment of value.
    The American journal of medicine, 1983, Jul-28, Volume: 75, Issue:1B

    Topics: Antibodies; Antibody-Coated Bacteria Test, Urinary; Bacteriological Techniques; Bacteriuria; Culture

1983

Other Studies

58 other studies available for lactic acid and Infections, Staphylococcal

ArticleYear
Minimum inhibitory concentrations of chlorhexidine- and lactic acid-based teat disinfectants: An intervention trial assessing bacterial selection and susceptibility.
    Journal of dairy science, 2022, Volume: 105, Issue:1

    Topics: Animals; Cattle; Cattle Diseases; Chlorhexidine; Disinfectants; Female; Lactic Acid; Mammary Glands,

2022
In vitro testing and efficacy of poly-lactic acid coating incorporating antibiotic loaded coralline bioceramic on Ti6Al4V implant against Staphylococcus aureus.
    Journal of tissue engineering and regenerative medicine, 2022, Volume: 16, Issue:12

    Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Gentamicins; Humans; In Vitro Techniques; La

2022
Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection.
    Nature microbiology, 2020, Volume: 5, Issue:10

    Topics: Biofilms; Biomarkers; Biosynthetic Pathways; Cytokines; Histone Deacetylases; Host-Pathogen Interact

2020
Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
    Journal of nanobiotechnology, 2021, Jan-07, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Biofilms; Drug Delivery Systems; Drug Liberation; Lactic Acid; Microbial Sens

2021
Diagnostic challenge: an atypical presentation of infective endocarditis.
    BMJ case reports, 2021, Jan-25, Volume: 14, Issue:1

    Topics: Bacteremia; Blood Culture; C-Reactive Protein; Diagnosis, Differential; Diarrhea; Dysentery; Early W

2021
Mechanistic insights into cell-free hemoglobin-induced injury during septic shock.
    American journal of physiology. Heart and circulatory physiology, 2021, 06-01, Volume: 320, Issue:6

    Topics: Acidosis; Acute Lung Injury; Animals; Blood Pressure; Dogs; Heart Ventricles; Hemoglobins; Iron; Lac

2021
Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug L

2017
Fecal coagulase-negative staphylococci from horses, their species variability, and biofilm formation.
    Folia microbiologica, 2019, Volume: 64, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Coagulase; Feces; Gastrointestinal Microbiome; Horses; Lac

2019
Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant.
    International journal of pharmaceutics, 2013, Aug-16, Volume: 452, Issue:1-2

    Topics: Adhesins, Bacterial; Adjuvants, Immunologic; Animals; Bacterial Vaccines; Cell Survival; Cells, Cult

2013
Linezolid-induced hyperlactatemia in a burn patient.
    Annales francaises d'anesthesie et de reanimation, 2013, Volume: 32, Issue:9

    Topics: Acetamides; Aged, 80 and over; Anti-Infective Agents; Burns; Female; Humans; Lactic Acid; Linezolid;

2013
A biodegradable antibiotic-impregnated scaffold to prevent osteomyelitis in a contaminated in vivo bone defect model.
    European cells & materials, 2014, Jun-08, Volume: 27

    Topics: Animals; Anti-Infective Agents; Biodegradable Plastics; Bone Regeneration; Clindamycin; Femur; Genta

2014
Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.
    Journal of orthopaedic surgery and research, 2014, Nov-19, Volume: 9

    Topics: Animals; Bone Development; Bone-Implant Interface; Calcium Phosphates; Lactic Acid; Male; Methicilli

2014
A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses.
    European cells & materials, 2015, Jan-02, Volume: 29

    Topics: Animals; Anti-Bacterial Agents; Bone Cements; Bone Nails; Coated Materials, Biocompatible; Dogs; Dru

2015
Antibacterial activity and biological performance of a novel antibacterial coating containing a halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Anti-Bacterial Agents; Cell Proliferation; Coated Materials, Biocompatible; Furans; Lactic

2015
MRSA as a rare cause of vaginitis.
    Infection, 2015, Volume: 43, Issue:6

    Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Bacterial Agents; Female; Humans; La

2015
Glycolytic dependency of high-level nitric oxide resistance and virulence in Staphylococcus aureus.
    mBio, 2015, Apr-07, Volume: 6, Issue:2

    Topics: Animals; Disease Models, Animal; Drug Tolerance; Female; Fermentation; Glycolysis; Lactic Acid; Mice

2015
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carr

2015
Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, Jan-28, Volume: 222

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides;

2016
Staphylococci Related to Farm Ostriches and Their Sensitivity to Enterocins.
    Foodborne pathogens and disease, 2016, Volume: 13, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bridged-Ring Compounds; Farms; Foodborne Diseases; Humans; Lactic Ac

2016
Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment.
    International journal of pharmaceutics, 2016, May-30, Volume: 505, Issue:1-2

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Chemistry, Pharmaceutical; Delayed-Action Preparations; D

2016
Fighting Off Wound Pathogens in Horses with Honeybee Lactic Acid Bacteria.
    Current microbiology, 2016, Volume: 73, Issue:4

    Topics: Animals; Bees; Bifidobacterium; Biological Therapy; Honey; Horse Diseases; Horses; Lactic Acid; Lact

2016
CNA-loaded PLGA nanoparticles improve humoral response againstS. aureus-mediated infections in a mouse model: subcutaneous vs. nasal administration strategy.
    Journal of microencapsulation, 2016, Volume: 33, Issue:8

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Drug Carriers; Female; Immunity, Humora

2016
Reduction of postoperative spinal implant infection using gentamicin microspheres.
    Spine, 2009, Mar-01, Volume: 34, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Nails; Delayed-Action Preparations; Dr

2009
Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Archives of orthopaedic and trauma surgery, 2010, Volume: 130, Issue:1

    Topics: Absorbable Implants; Analysis of Variance; Animals; Anti-Bacterial Agents; Disease Models, Animal; D

2010
Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:1

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotic Prophylaxis; Aqueous Humor; Bio

2010
Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study.
    Archives of orthopaedic and trauma surgery, 2011, Volume: 131, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Discitis; Lactic Acid; Methicillin-Resistan

2011
Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets.
    Journal of biomaterials applications, 2012, Volume: 27, Issue:2

    Topics: Absorbable Implants; Anti-Bacterial Agents; Drug Delivery Systems; Humans; Lactic Acid; Nuclear Magn

2012
Vancomycin containing PLLA/β-TCP controls MRSA in vitro.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:11

    Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Substitutes; Calcium Phosphates; Cell Adhesion;

2011
Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2012, Volume: 80, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Biofilms; Cellular M

2012
Microfluidic 3D bone tissue model for high-throughput evaluation of wound-healing and infection-preventing biomaterials.
    Biomaterials, 2012, Volume: 33, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Calcium Phosphates; Cell Li

2012
Modification of TiO(2) nanotube surfaces by electro-spray deposition of amoxicillin combined with PLGA for bactericidal effects at surgical implantation sites.
    Acta odontologica Scandinavica, 2013, Volume: 71, Issue:1

    Topics: 3T3 Cells; Amoxicillin; Animals; Anti-Bacterial Agents; Bone Plates; Cell Adhesion; Cell Proliferati

2013
Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection.
    Veterinary research, 2012, Mar-19, Volume: 43

    Topics: Adjuvants, Immunologic; Animals; Bacterial Vaccines; Enterotoxins; Female; Lactic Acid; Mice; Polygl

2012
A lipid-and-polymer-based novel local drug delivery system--BonyPid™: from physicochemical aspects to therapy of bacterially infected bones.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Jun-10, Volume: 160, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Chemical Phenomena; Coated Materials, Biocompati

2012
Formulation, antimicrobial and toxicity evaluation of bioceramic based ofloxacin loaded biodegradable microspheres for periodontal infection.
    Current drug delivery, 2012, Volume: 9, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chemistry, Pharmaceutical; Escherichia coli; Escheric

2012
Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings.
    Biomaterials, 2012, Volume: 33, Issue:32

    Topics: Anti-Bacterial Agents; Azo Compounds; Biofilms; Coated Materials, Biocompatible; Escherichia coli; E

2012
Identification of a lactate-quinone oxidoreductase in Staphylococcus aureus that is essential for virulence.
    Frontiers in cellular and infection microbiology, 2011, Volume: 1

    Topics: Animals; Bacterial Proteins; Disease Models, Animal; Genes, Bacterial; Host-Pathogen Interactions; H

2011
Bioabsorbable poly-L-lactic acid cages for lumbar interbody fusion: three-year follow-up radiographic, histologic, and histomorphometric analysis in goats.
    Spine, 2002, Dec-01, Volume: 27, Issue:23

    Topics: Absorbable Implants; Animals; Bone Remodeling; Drug Implants; Elasticity; Feasibility Studies; Femal

2002
Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants.
    Microbial drug resistance (Larchmont, N.Y.), 2002,Winter, Volume: 8, Issue:4

    Topics: Acetates; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Glucose; Hydrogen-Ion Co

2002
THE ROLE OF LACTATE IN REGULATION OF THE ENZYMATIC SYSTEM SYNTHESIS PARTICIPATING IN THE ACETATE OXIDATION IN STAPHYLOCOCCUS AUREUS.
    Biochemical and biophysical research communications, 1963, Sep-10, Volume: 13

    Topics: Acetates; Citric Acid Cycle; Lactates; Lactic Acid; Metabolism; Oxidation-Reduction; Research; Staph

1963
GLYCOGEN AND LACTIC ACID IN RABBIT'S PERIPHERAL BLOOD IN THE COURSE OF ACUTE STAPHYLOCOCCUS INFECTION.
    Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques, 1965, Volume: 13

    Topics: Animals; Blood; Communicable Diseases; Glycogen; Lactates; Lactic Acid; Lagomorpha; Rabbits; Researc

1965
Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model.
    Clinical orthopaedics and related research, 2004, Issue:421

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Cefazolin; Disease Models, Animal; Drug Car

2004
Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bone Cements; Ciprofloxacin; Coated Materials, Biocompatible; Diseas

2005
The bacteriostatic properties of ear tubes made of absorbable polylactic acid.
    International journal of pediatric otorhinolaryngology, 2006, Volume: 70, Issue:3

    Topics: Absorbable Implants; Anti-Infective Agents; Child; Humans; Lactic Acid; Middle Ear Ventilation; Otit

2006
Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects.
    Journal of microencapsulation, 2006, Volume: 23, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biocompatible Materials; Bone Transplantatio

2006
pH value promotes growth of Staphylococcus epidermidis in platelet concentrates.
    Transfusion, 2008, Volume: 48, Issue:5

    Topics: Bacteremia; Blood Donors; Blood Platelets; Blood Preservation; Citrates; Cryopreservation; Humans; H

2008
[Lactate determination in the cerebrospinal fluid. Differential diagnostic significance].
    MMW, Munchener medizinische Wochenschrift, 1981, Oct-02, Volume: 123, Issue:40

    Topics: Diagnosis, Differential; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Lactate

1981
Comparison of Staphylococcus aureus and Escherichia coli infusion in conscious rats.
    The Journal of surgical research, 1994, Volume: 56, Issue:1

    Topics: Animals; Bacteremia; Blood Glucose; Carbon Dioxide; Cardiac Output; Escherichia coli; Escherichia co

1994
[The enzyme activity and pyruvate, lactate and 2,3-DPG levels in the erythrocytes of patients with severe forms of meningococcal infection and suppurative meningitis].
    Terapevticheskii arkhiv, 1996, Volume: 68, Issue:2

    Topics: 2,3-Diphosphoglycerate; Adolescent; Adult; Aged; Diphosphoglyceric Acids; Erythrocytes; Female; Huma

1996
Treatment of osteomyelitis with a biodegradable antibiotic implant.
    Clinical orthopaedics and related research, 1997, Issue:341

    Topics: Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Disease Models, Animal; Drug Delivery

1997
Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections.
    International orthopaedics, 1997, Volume: 21, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biodegradation, Environmental; Calcium Sulf

1997
Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 1999, Volume: 4, Issue:5

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Apatites; Bone Cements; Bone Marrow; Bone T

1999
Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:2

    Topics: Animals; Anti-Infective Agents; Colony Count, Microbial; Drug Implants; Excipients; Lactic Acid; Mal

2000
Evaluation of postmilking teat germicides containing Lauricidin, saturated fatty acids, and lactic acid.
    Journal of dairy science, 1992, Volume: 75, Issue:6

    Topics: Animals; Cattle; Disinfectants; Fatty Acids; Female; Glycerides; Lactates; Lactic Acid; Laurates; Ma

1992
Effect of postmilking teat antisepsis on teat canal infections in lactating dairy cows.
    Journal of dairy science, 1990, Volume: 73, Issue:2

    Topics: Animals; Antisepsis; Cattle; Fatty Acids; Female; Iodophors; Lactates; Lactation; Lactic Acid; Masti

1990
[Spontaneous bacterial peritonitis: studies of the incidence and clinical and laboratory chemical parameters].
    Zeitschrift fur Gastroenterologie, 1990, Volume: 28, Issue:7

    Topics: Ascitic Fluid; Bacterial Infections; Bacteriological Techniques; Blood Glucose; Blood Proteins; Chol

1990
The effects of chronic bacteremia on the metabolic response to exercise in the conscious rat.
    Circulatory shock, 1988, Volume: 25, Issue:4

    Topics: Acid-Base Equilibrium; Animals; Bacteroides fragilis; Bacteroides Infections; Blood Gas Analysis; Bl

1988
The effect of dialysate on peritoneal phagocyte oxidative metabolism.
    Kidney international, 1988, Volume: 34, Issue:3

    Topics: Dialysis Solutions; Humans; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Luminescent Measureme

1988
Septic arthritis. Clinical approach to the 'hot joint'.
    Postgraduate medicine, 1986, Feb-01, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Child; Diagn

1986